Keywords
Asthma
Infection
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To relate the case of a patient who caused a bronchial asthma condition after the SARS-CoV-2 infection. Case details: The described case is about a female patient, non-smoker, non-diabetic, 55 years old, nurse, brown, without history of asthma. The patient presented symptoms to Covid-19 and was diagnosed on 06/20/2020. A month later of the symptoms, the patient demonstrated illness, fatigue and dry cough, making her looking for an Emergency Care Unit (ECU). Posteriorly, with the persistence and the intensity of symptoms, the patient sought a pulmonologist. Then the clinical evaluation, the imaging exams and spirometry, clinical diagnoses were excluded and Relvar 100/25 mcg per day was prescribed. However, It didn’t have an effect. The new episodes came with dyspnea. Promptly, there was a search for a second pulmonologist. In the clinical evaluation, it identified hisses on auscultation and soughted imaging exams. Thus, there was a clinical diagnosis of asthma. Therefore, the Relvar dose increased to 200/25 mcg with a satisfied therapeutic response. In this scenario, it was possible to evaluate the association between SARS-CoV-2 and asthma. Final considerations: This discussion is relevant to the scientific field due to absence of references in the literature about the asthma development by Covid-19 infection.
References
AKBARIALIABAD H, et al. Long COVID, a comprehensive systematic scoping review. Infection, 2021; 49(6): 1163-1186.
ARMANDO D. Asma e COVID-19–Relação de Reciprocidade ou Dualidade?. Cíências de Saúde, 2021; 7(1): 55.
ARNOLD, DT. et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax, 2021; 76(4): 399-401.
BAKAKOS A, et al. Unraveling the Relationship of Asthma and COVID-19. Journal of Personalized Medicine, 2021; 11(12): 1374.
BALDI BG, TANNI SE. Fibrose pulmonar e acompanhamento de sobreviventes da COVID-19: necessidade urgente de esclarecimento. Jornal Brasileiro de Pneumologia, 2021; 47.
BOUTELEUX B, et al. Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience. Respiratory medicine, 2021; 189: 106648.
CARES-MARAMBIO K, et al. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chronic respiratory disease, 2021; 18.
CARFÌ A, et al. Persistent symptoms in patients after acute COVID-19. Jama, 2020; 324(6): 603-605.
CORTÉS-TELLES A, et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respiratory Physiology & Neurobiology, 2021; 288: 103644.
DE LORENZO R, et al. Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS One, 2020; 15(10): e0239570.
GALVÃO MHR, RONCALLI AG. Fatores associados a maior risco de ocorrência de óbito por COVID-19: análise de sobrevivência com base em casos confirmados. Revista Brasileira de Epidemiologia, 2021; 23: e200106.
GARRIGUES E, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection, 2020; 81(6): e4-e6.
HEFFLER E, et al. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments. Authorea Preprints, 2020.
HUANG C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, 2021; 397(10270): 220-232.
HULL JH,. et al. Lung function testing in the COVID-19 endemic. The Lancet Respiratory Medicine, 2020; 8(7): 666-667.
IQBAL A, et al. The COVID-19 sequelae: a cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus, 2021; 13(2).
JENNINGS G, et al. A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: Ongoing symptomatic phase vs. post-COVID-19 syndrome. Journal of Clinical Medicine, 2021; 10(24): 5913.
MAINOUS III AG, et al. COVID-19 Post-acute Sequelae Among Adults: 12 Month Mortality Risk. Frontiers in Medicine, 2021; 2351.
MANDAL S, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax, 2021; 76(4): 396-398.
MATOS-FERREIRA G. COVID-19: Beyond the Acute Phase. Acta Med Port., 2021; 10(12): 13-14.
QU G, et al. Health‐related quality of life of COVID‐19 patients after discharge: A multicenter follow‐up study. Journal of clinical nursing, 2021; 30(11): 1742-1750.
RODRIGUES AS, et al. Abordagem geral da asma: uma revisão narrativa. Revista Eletrônica Acervo Médico, 2021, 1(2): e9129-e9129.
SHAH AS, et al. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax, 2021; 76(4): 402-404.
SOUSA AR, et al. Symptomatic manifestations of the disease caused by coronavirus (COVID-19) in adults: systematic review. Revista Gaúcha de Enfermagem, 2021; 42.
TOSATO M, et al. Prevalence and predictors of persistence of COVID-19 symptoms in older adults: A single-center study. Journal of the American Medical Directors Association, 2021; 22(9): 1840-1844.
WEI J, et al. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. Journal of X-ray Science and Technology, 2020; 28(3): 383-389.
WU L, et al. Persistence of symptoms after discharge of patients hospitalized due to COVID-19. Frontiers in Medicine, 2021.
WU X, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. The Lancet Respiratory Medicine, 2021.
YOU J, et al. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. Journal of Infection, 2020; 81(2): e150-e152.
ZHAO Y, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine, 2020; 25.